Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer
Scott A. Tomlins(Michigan Center for Translational Pathology), Bharathi Laxman(Michigan Center for Translational Pathology), Saravana M. Dhanasekaran(Michigan Center for Translational Pathology), Beth E. Helgeson(Michigan Center for Translational Pathology), Xuhong Cao(Michigan Center for Translational Pathology), David S. Morris, Anjana Menon(Michigan Center for Translational Pathology), Xiaojun Jing(Michigan Center for Translational Pathology), Qi Cao(Michigan Center for Translational Pathology), Bo Han(Michigan Center for Translational Pathology), Jindan Yu(Michigan Center for Translational Pathology), Lei Wang(Michigan Center for Translational Pathology), James E. Montie(University of Michigan–Ann Arbor), Mark A. Rubin(Dana-Farber Cancer Institute), Kenneth J. Pienta(University of Michigan–Ann Arbor), Diane Roulston(Michigan Center for Translational Pathology), Rajal B. Shah(University of Michigan–Ann Arbor), Sooryanarayana Varambally(Michigan Center for Translational Pathology), Rohit Mehra(University of Michigan–Ann Arbor), Arul M. Chinnaiyan(University of Michigan–Ann Arbor)
Cited by 843Open Access